-
srdr.ahrq.gov/projects/1626/studies/193201
January 01, 2009 - Study Preview
Study Title and Description
Medicaid patients at high risk … for frequent hospital admission: real-time identification and remediable risks. … Post/View
Title Data
Title
Medicaid patients at high risk … for frequent hospital admission: real-time identification and remediable risks.
-
srdr.ahrq.gov/projects/1603/studies/197999
January 01, 1999 - vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk … a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs … vaginal cream to reduce the incidence of spontaneous preterm birth in women with an increased recurrence risk
-
srdr.ahrq.gov/projects/1596
November 22, 2019 - use was identified through primary care-based screening with questions about drug use or drug-related risks … screened for drug use in primary care or other settings with questions about drug use or drug-related risks … In treatment-seeking populations with opioid use disorder, naltrexone (12 trials; relative risk [RR] … Evidence on harms of pharmacotherapies was limited, but indicated no increased risk of serious adverse … In treatment-seeking populations with opioid use disorder, naltrexone (12 trials; relative risk [RR]
-
srdr.ahrq.gov/projects/1603
February 16, 2021 - a) Does the effect of screening vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of screening vary by other risks for preterm delivery (e.g., coinfection with STIs … a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs … Sonnex C.
1995
Safety of metronidazole during pregnancy: a cohort study of risk of congenital
-
srdr.ahrq.gov/projects/1603/studies/197971
January 01, 1995 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197985
January 01, 1994 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1591/studies/192133
January 01, 2017 - effectiveness of guided weight loss and physical activity monitoring for weight loss and metabolic risks … Which patients in which settings are most at risk of harms? … effectiveness of guided weight loss and physical activity monitoring for weight loss and metabolic risks
-
srdr.ahrq.gov/projects/1591/studies/195478
January 01, 2017 - effectiveness of guided weight loss and physical activity monitoring for weight loss and metabolic risks … Which patients in which settings are most at risk of harms? … effectiveness of guided weight loss and physical activity monitoring for weight loss and metabolic risks
-
srdr.ahrq.gov/projects/1603/studies/197969
January 01, 2003 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197984
January 01, 1994 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1312/studies/133191
January 01, 2007 - Title and Description
A green tea extract high in catechins reduces body fat and cardiovascular risks … 1
Is dietary intake of flavan-3ols associated with cardiovascular health outcomes and risk … Data
Title
A green tea extract high in catechins reduces body fat and cardiovascular risks … Comments ( 0 ) |
Post/View
Adults at an increased risk … Comments ( 0 ) |
Post/View
Adults at an increased risk
-
srdr.ahrq.gov/projects/1603/studies/197976
January 01, 2004 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197979
January 01, 2006 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197977
January 01, 2003 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/198001
January 01, 2003 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197983
January 01, 1997 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197975
January 01, 2001 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197996
January 01, 2018 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1603/studies/197962
January 01, 2000 - a) Does the effect of treatment vary by baseline risk (e.g., low- vs. high-risk) for preterm delivery … e) Does the effect of treatment vary by other risks for preterm delivery (e.g., coinfection with STIs
-
srdr.ahrq.gov/projects/1634/studies/193574
January 01, 2019 - reinduction treatment, or had relapsed within 1 year of the initial treatment, excluding those with favorable risk … reinduction treatment, or had relapsed within 1 year of the initial treatment, excluding those with favorable risk … Out of the 280 subjects who had RR AML.
141/280 were intermediate risk.
69/280 were poor risk.
70 … Out of the 280 subjects who had RR AML.
141/280 were intermediate risk.
69/280 were poor risk.
70